Escala de Bienestar Subjetivo en Cuidadores Familiares de Adultos Mayores (EBEMS/CFAM)

Well-being is a concept that has aroused multidisciplinary interest. Particularly in studies about family caregivers of older adults there has been the need to analyze this attribute facing the imminent increase of family caregivers. The goal of this paper is to describe the design process, the exploratory and confirmatory validation, as well as the usefulness of the current Scale of Subjective Well-Being of Family Caregivers for Older Adults - EBEMS/ CFAM. Results are shown in a sequence, from qualitative analysis, to factor analysis, Rasch modeling and structural equations in four samples of study that, taken together, confirm the validity and reliability of the scale.El bienestar es un concepto que ha despertado un interés multidisciplinar y particularmente en la línea de estudios sobre cuidadores familiares de adultos mayores se ha registrado la necesidad de analizar dicho atributo ante el inminente aumento de familias cuidadoras. El objetivo de este trabajo es describir el proceso de diseño, validación exploratoria y confirmatoria, así como la utilidad actual de la Escala de Bienestar Subjetivo para Cuidadores Familiares de Adultos Mayores � EBEMS/CFAM. Se presenta una secuencia de resultados de análisis cualitativos, análisis factoriales, de modelamiento Rasch y ecuaciones estructurales en cuatro muestras de estudio que, en conjunto, confirman la validez y confiabilidad de la escal

International Nosocomial Infection Control Consortiu (INICC) report, data summary of 43 countries for 2007-2012. Device-associated module

We report the results of an International Nosocomial Infection Control Consortium (INICC) surveillance study from January 2007-December 2012 in 503 intensive care units (ICUs) in Latin America, Asia, Africa, and Europe. During the 6-year study using the Centers for Disease Control and Prevention's (CDC) U.S. National Healthcare Safety Network (NHSN) definitions for device-associated health care–associated infection (DA-HAI), we collected prospective data from 605,310 patients hospitalized in the INICC's ICUs for an aggregate of 3,338,396 days. Although device utilization in the INICC's ICUs was similar to that reported from ICUs in the U.S. in the CDC's NHSN, rates of device-associated nosocomial infection were higher in the ICUs of the INICC hospitals: the pooled rate of central line–associated bloodstream infection in the INICC's ICUs, 4.9 per 1,000 central line days, is nearly 5-fold higher than the 0.9 per 1,000 central line days reported from comparable U.S. ICUs. The overall rate of ventilator-associated pneumonia was also higher (16.8 vs 1.1 per 1,000 ventilator days) as was the rate of catheter-associated urinary tract infection (5.5 vs 1.3 per 1,000 catheter days). Frequencies of resistance of Pseudomonas isolates to amikacin (42.8% vs 10%) and imipenem (42.4% vs 26.1%) and Klebsiella pneumoniae isolates to ceftazidime (71.2% vs 28.8%) and imipenem (19.6% vs 12.8%) were also higher in the INICC's ICUs compared with the ICUs of the CDC's NHSN